Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart  has been straight up and to the right, up 553% and ...
Shares of weight loss drugmakers Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) extended a multi-day decline on Thursday, losing ...
The healthcare company hasn't done a stock split in decades; its last one was a 2-for-1 back in 1997. While that's ...
Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating on Eli Lilly with a price target of $885. Eli Lilly's ...
Eli Lilly (NYSE: LLY) stock has been a winner for investors of late, owing largely to strong consumer demand for obesity ...
Eli Lilly will acquire biopharmaceutical firm Morphic Holding in a deal valued at $3.2 billion, both companies announced ...
GLP-1 market leaders Eli Lilly and Company (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) faced a significant selloff on Thursday, as new weight-loss drugs from rival pharmaceutical companies began ...
Eli Lilly, with a market value of nearly $900 billion, has vaulted past Tesla into the top 10 list of U.S. companies.
Lilly is promoting Mounjaro despite facing supply constraints. Anat Ashkenazi, chief financial officer at Lilly, told ...
Eli Lilly and Company (NYSE:LLY) stock is moving lower on Thursday on possible continued weakness after recent weight loss ...